End-Payor Actions Consolidated In Propranolol Antitrust Row
A New York federal judge Thursday consolidated two end-payer cases in a proposed class action alleging that drugmakers conspired to jack up the price of generic blood pressure medication propranolol, and...To view the full article, register now.
Already a subscriber? Click here to view full article